期刊
ONCOGENE
卷 27, 期 46, 页码 5975-5987出版社
SPRINGERNATURE
DOI: 10.1038/onc.2008.213
关键词
immortalization; senescence; cell cycle; interferon; cytoskeletal; IGF-related genes
资金
- Barbara Ann Karmanos Cancer Institute
- State of Michigan Life Sciences Corridor
- Wayne State University
- Michigan Center for Genomic Technologies Applied Genomics Technology Center [MEDC 085P10009816]
- Genomics and Biostatistics Cores of the Barbara Ann Karmanos Cancer Institute [P30CA022453]
Bypassing cellular senescence and becoming immortal is a prerequisite step in the tumorigenic transformation of a cell. It has long been known that loss of a key tumor suppressor gene, such as p53, is necessary, but not sufficient, for spontaneous cellular immortalization. Therefore, there must be additional mutations and/or epigenetic alterations required for immortalization to occur. Early work on these processes included somatic cell genetic studies to estimate the number of senescence genes, and microcell-mediated transfer of chromosomes into immortalized cells to identify putative senescence-inducing genetic loci. These principal studies laid the foundation for the field of senescence/immortalization, but were labor intensive and the results were somewhat limited. The advent of gene expression pro. ling and bioinformatics analysis greatly facilitated the identification of genes and pathways that regulate cellular senescence/ immortalization. In this review, we present the findings of several gene expression pro. ling studies and supporting functional data, where available. We identified universal genes regulating senescence/ immortalization and found that the key regulator genes represented six pathways: the cell cycle pRB/p53, cytoskeletal, interferon-related, insulin growth factor-related, MAP kinase and oxidative stress pathway. The identification of the genes and pathways regulating senescence/ immortalization could provide novel molecular targets for the treatment and/or prevention of cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据